SCHEMBL14970638

SCHEMBL14970638

CC1=NN(c2ccc(C)c(C)c2)C(=O)C1=NNc1ccccc1O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.38
KDM4E B2RXH2 4/20 0.38
KMT2A Q03164 8/20 0.37
MEN1 O00255 7/20 0.37
GAA P10253 3/20 0.37
TDP1 Q9NUW8 1/20 0.37
MAPT P10636 7/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
HPGD P15428 2/20 0.36
POLB P06746 2/20 0.34
NPC1 O15118 4/20 0.34
RAB9A P51151 4/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
CASP6 P55212 1/20 0.34
ATM Q13315 1/20 0.34
STAT1 P42224 1/20 0.33
MAPK1 P28482 2/20 0.32
KAT8 Q9H7Z6 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16596981 1.00 ALDH1A1 (0.38) ALDH1A1KDM4EKMT2AMEN1GAA
SCHEMBL1743260 0.87 MEN1 (0.36) ALDH1A1KDM4EKMT2AMEN1GAA
SCHEMBL12316751 0.87 MAPT (0.48) ALDH1A1KDM4EKMT2AMEN1GAA
SCHEMBL16596970 0.85 MEN1 (0.37) ALDH1A1KDM4EKMT2AMEN1GAA
SCHEMBL14969012 0.85 MEN1 (0.37) ALDH1A1KDM4EKMT2AMEN1GAA
SCHEMBL14966103 0.85 MEN1 (0.37) ALDH1A1KDM4EKMT2AMEN1GAA
SCHEMBL31415058 0.85 MEN1 (0.37) ALDH1A1KDM4EKMT2AMEN1GAA
SCHEMBL14970702 0.84 KMT2A (0.42) ALDH1A1KDM4EKMT2AMEN1GAA
SCHEMBL16596971 0.84 KMT2A (0.42) ALDH1A1KDM4EKMT2AMEN1GAA
SCHEMBL1742069 0.84 MEN1 (0.38) ALDH1A1KDM4EKMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9440927-B2 Process for preparation of substituted 3'-hydroazino-diphenyl-3-carboxylic acid compounds GLENMARK PHARMACEUTICALS LIMITED (IN) 2016-09-13 US disclosed
US-20150087845-A1 PROCESS FOR PREPARATION OF SUBSTITUTED 3'-HYDROAZINO-DIPHENYL-3-CARBOXYLIC ACID COMPOUNDS GLENMARK GENERICS LIMITED (IN) 2015-03-26 US disclosed
WO-2013072921-A2 PROCESS FOR PREPARATION OF SUBSTITUTED 3'-HYDRAZINO-BIPHENYL-3-CARBOXYLIC ACID COMPOUNDS GLENMARK GENERICS LIMITED (IN) 2013-05-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150087845-A1 PROCESS FOR PREPARATION OF SUBSTITUTED 3'-HYDROAZINO-DIPHENYL-3-CARBOXYLIC ACID COMPOUNDS CYP3A5, UGT1A3, HPD ALDH1A1 52/4885KDM4E 580/4885KMT2A 702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.